• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
Endogenex

Endogenex

Bringing New Energy to the Treatment of Type 2 Diabetes

  • T2D
  • ReCET
  • Patients
  • Clinical Providers
  • About Us
    • News
    • Contact
  • ReCET Study

Patients

Taking control of your
treatment options

Seeking innovative methods to manage type 2 diabetes

ReCET by Endogenex is a new investigational procedure designed to help people living with type 2 diabetes (T2D) bring control to their blood sugar levels.

Research has shown that cells in a portion of the small intestine, called the duodenum, play an important role in managing blood sugar levels.9  In individuals with type 2 diabetes, malfunctioning cells in the duodenum can lead to poor blood sugar control.

Treatment for type 2 diabetes

Current treatments for T2D focus primarily on lifestyle adjustments (diet and exercise) and medications, including insulin. An adult diagnosed with diabetes in the US uses an average of 5.9 different medications.4 Managing these medications and their side effects can be challenging; the costs of these medications can be significant.

The ReCET Procedure is an investigational treatment designed to promote the regeneration of healthy signaling cells in the duodenum, which, in turn, may help the body manage blood sugar levels and slow progression of the disease.

During the ReCET Procedure, a physician will use a small camera to help guide a special catheter from the mouth down to the first part of your small intestine. Once the catheter is in place, it delivers precise, controlled electrical pulses into the wall of the duodenum. These electrical pulses are intended to disrupt the poorly functioning signaling cells and start your body’s process of replacing them with new cells to help better manage your blood sugar levels.

You are asleep during the ReCET Procedure and are able to go home the same day of the procedure. Most patients are able to start their normal activities the day after the procedure is done.

The ReCET System is currently under evaluation in the ReCET Clinical Study.

To learn more about ReCET and participation opportunities, visit recetstudy.com.

* Caution: Exclusively a clinical investigational device. Limited by federal (or United States or similar) law to investigational use. Not for sale in any geography.

Please refer to your physician for additional information on the ReCET Procedure, ReCET System, and related risks.

Endogenex, Inc.
13755 1st Avenue North #100
Plymouth, MN 55441
+1 763-251-6820
info@endogenex.com

References

Terms of Use

Privacy Policy

Cookie Policy

EndogenexTM and ReCETTM are registered trademarks of Endogenex, Inc. in the United States and other countries. Copyright © 2025 Endogenex, Inc. All rights reserved.

  • LinkedIn
  • X
  • Vimeo